DuPont announces $250M share repurchase in Q3 2026
Chemical company to repurchase shares during third quarter as it raises full-year guidance following strong Q2 earnings.
What the filing says
DuPont de Nemours, Inc. announced on August 4, 2026, its intention to repurchase $250 million of common shares during the third quarter of 2026, according to its second-quarter earnings release filed as an 8-K. The repurchase announcement came as the company raised its full-year 2026 financial guidance following stronger-than-expected second-quarter results.
The $250 million Q3 repurchase is part of a broader $2 billion share buyback program that the company announced on November 6, 2025, as noted in the forward-looking statements section of the filing. The filing does not specify the execution mechanism for the Q3 repurchase (whether Rule 10b-18 open-market purchases, accelerated share repurchase, or other means) or disclose the number of shares to be repurchased at any particular price.
DuPont's second-quarter earnings benefited from 4% organic sales growth, operating EBITDA of $448 million, and adjusted EPS of $1.88, supporting management's decision to raise midpoint guidance for full-year 2026 operating EBITDA to approximately $1.76 billion and adjusted EPS to $7.24 per share. The company generated $326 million in transaction-adjusted free cash flow in Q2, representing 127% conversion of adjusted earnings.
Announces intent to repurchase $250 million of shares in the third quarter — DuPont de Nemours, Inc. 8-K filing · View on SEC EDGAR →
What this means
Frequently asked questions
- What is the size and timing of DuPont's announced share repurchase?
- DuPont announced an intent to repurchase $250 million of common shares during the third quarter of 2026. This repurchase is part of a broader $2 billion share buyback program authorized by the company's Board on November 6, 2025.
- How does this repurchase relate to DuPont's larger buyback authorization?
- The $250 million Q3 repurchase is a quarterly installment from the $2 billion program announced in November 2025. The filing notes that completion of the $2 billion authorization is subject to risks, timing uncertainties, and the possibility that the program may be suspended or discontinued before completion.
- What execution mechanism will DuPont use for the repurchase?
- The filing does not specify whether DuPont will use Rule 10b-18 open-market purchases, an accelerated share repurchase, a 10b5-1 plan, or another mechanism. Details are stated as not specified in the filing.
- What was DuPont's financial performance in Q2 2026 that prompted this repurchase announcement?
- DuPont reported Q2 2026 net sales of $1.819 billion (up 4%), operating EBITDA of $448 million, adjusted EPS of $1.88 (up 48%), and transaction-adjusted free cash flow of $326 million. Strong performance led management to raise full-year 2026 guidance for operating EBITDA and adjusted EPS.
- Has DuPont executed any share repurchases in 2026 prior to this announcement?
- Yes. The company's cash flow statement shows that DuPont purchased $275 million of common stock and forward contracts in the first half of 2026, reflecting ongoing execution of the $2 billion program before the Q3 announcement.
- How many shares did the reverse stock split affect before this repurchase?
- On June 24, 2026, DuPont's Board implemented a 1-for-3 reverse stock split, reducing the share count proportionally. All share counts and EPS figures in the filing are retroactively adjusted for this split. The company had 135.9 million basic weighted-average shares outstanding in Q2 2026 post-adjustment.